Framingham Heart Study Original Cohort (BioLINCC)
National Heart, Lung, and Blood Institute (NHLBI)
5,209 people from one Massachusetts town, examined every two years since 1948.
The original cohort of the Framingham Heart Study, which enrolled 5,209 adults in Framingham, Massachusetts, in 1948-1952 and examined them every two years. The study identified blood pressure, cholesterol, and smoking as heart disease risk factors. BioLINCC distributes data from the first 32 exams plus event follow-up; offspring and third-generation cohorts are separate requests.
Access
- Cost
- By applicationNo fee is stated for BioLINCC access; requires an account and full or expedited IRB approval (exemptions do not suffice).
- License
- Provider's own termsBioLINCC Research Materials Distribution Agreement
- Sign-up
- Application required
- How you get it
- Through the provider's siteSAS
What's in it
- One row is
- One row per participant per exam, with event files
- Covers
- Framingham, Massachusetts
- Years
- 1948-2018 (event follow-up)
- Updated
- Irregular
- Size
- 5,209 participants, 32 exams
Quality
The founding cohort study of cardiovascular epidemiology, with seven decades of standardized exams and adjudicated events.
- Almost entirely white participants from one town
- Exam content changed over decades
- Commercial use is restricted by tiered consent
Connects to
- UK Biobank: A modern, much larger cohort for replicating risk factor findings
- CDC WONDER Multiple Cause of Death: National heart disease mortality trends for context
Questions it could answer
- How well does a 1970s-era risk model predict heart attacks in later exam waves?
- How did smoking cessation change participants' subsequent event rates?